The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 5.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (3 analysts) rates it strong buy, with a mean price target of $39.
Prudential plc ADR PUK
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Prudential plc, through its subsidiaries, provides life and health insurance, and asset management solutions to individuals in Asia and Africa.
read at $27.95
Prudential plc ADR holds its Markup at $27.95.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Elevated stress, defensive posture warranted, held for 1 days |
| Price | $27.95 |
| Valuation | 9.10 trailing · 14.04 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.90 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 18.80% |
| Profit margin | 27.57% |
| Debt to equity | 28.25 |
| Analyst consensus | Buy · 3 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its excluded industry: insurance - life. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Excluded industry: Insurance - Life Fail
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity of revenue comes from non-compliant sources, over the 5% line. Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Asia life cover growth hits ethical wall
Families across Asia and Africa pay premiums for protection and savings through Prudential, a business posting 19 percent revenue growth, 28 percent profit margins and 21 percent ROE at a forward multiple of 13 times. Yet the numbers never reach our desk. The ethical screen rejects life insurance outright, so the 26 percent margin of safety to fair value stays irrelevant.
We pass for one clear reason. An excluded industry means the investment case stops before valuation or narrow moat analysis begins. Three analysts see a $39 median target, but none of that matters once the screen has spoken.
Insurance carries its own long-term risks around claims, regulation and currency moves in emerging markets. None of those risks get weighed here. Analysis, not advice.
| Forward P/E | 14.0x cheap for a company growing this fast |
| Trailing P/E | 9.1x very cheap relative to earnings |
| Revenue growth | 18.8% steady growth |
| Profit margin | 27.6% healthy profit margins |
| Return on equity | 20.6% an exceptional return on shareholder capital |
| Debt to equity | 0.28 minimal debt — a conservative balance sheet |
| Current ratio | 2.39 comfortably covers its short-term bills |
| Beta | 0.90 steadier than the market |
| Market cap | $34.8B |
| Employees | 15,338 |
The risks · The things to watch: its business and earnings are exposed to Hong Kong and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on PUK
- › European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading MT Newswires · 1 Jul 2026
- › European Equities Traded in US as ADRs Rise in Thursday Trading MT Newswires · 25 Jun 2026
- › Prudential’s (PUK) Prudence Foundation Launches Levela App to Improve Financial Literacy in Asia and Africa Insider Monkey · 23 Jun 2026
- › AIA, Prudential Chase Asia's Wealth Insurance Boom GuruFocus.com · 16 Jun 2026
- › The Bigger Story Behind Prudential’s (PUK) Lower Price Target Insider Monkey · 12 Jun 2026
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in PUK's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (3 analysts) rates it strong buy, with a mean price target of $39.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $31.32 | -19.9% | · | $801 | -19.9% |
| 2 months | $30.30 | -17.2% | · | $828 | -17.2% |
| 3 months | $28.70 | -12.6% | $0.38 | $887 | -11.3% |
| 6 months | $29.15 | -14.0% | $0.38 | $873 | -12.7% |
| 1 year | $23.34 | +7.4% | $0.53 | $1,097 | +9.7% |
| 2 years | $17.79 | +41.0% | $1.00 | $1,466 | +46.6% |
| 3 years | $26.46 | -5.2% | $1.40 | $1,001 | +0.1% |
| 5 years | $37.34 | -32.9% | $2.12 | $728 | -27.2% |
Historical returns from market close data. Past performance does not guarantee future results.